CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 10 No. 8
Pages: 1  2  
Next
 

Detection of Nodal Micrometastases in Head and Neck Cancer by Serial Sectioning and Immunostaining

By Petra Ambrosch, MD,Department of Otorhinolaryngology, Head and Neck Surgery
Ulrich Brinck, MD,Department of Pathology
Georg-August-University of Göttingen, Göttingen, Germany | August 1, 1996

We investigated the incidence of micrometastases from squamous cell carcinomas of the head and neck in neck dissection specimens originally staged as pN0. A total of 76 dissection specimens from 60 patients were evaluated using serial microscopic sectioning in 10-mm intervals, H & E staining, and immunostaining with an antibody to pan-cytokeratin. Examination of 1,020 lymph nodes from 76 neck dissection specimens revealed 8 micrometastases (7.9%) in 6 specimens from 6 patients with oral and pharyngeal primaries, resulting in upstaging. Six micrometastases were located in lymph nodes 3 to 6 mm in diameter. The surgeon should be aware of the relatively high incidence of micrometastases from oral and pharyngeal carcinomas, which are undetectable preoperatively or by routine histopathologic examination. Primary tumor site (oral cavity and pharynx) and certain features of the primary can delineate a group of patients with a higher risk of harboring occult metastases who may benefit from elective treatment of the neck. [ONCOLOGY 10(8):1221-1226, 1996]



Introduction

The status of the cervical lymph nodes is the most important prognostic factor in squamous cell carcinoma of the upper aerodigestive tract. The number of positive nodes and the presence of extranodal (or extracapsular) spread are the two most commonly used prognostic factors. Other characteristics of prognostic importance are the size of the node, level of positive nodes, and histologic response to the tumor in the node. The extent of nodal disease in the neck has prognostic significance not only for failure in the neck but also for the development of distant metastases and, possibly, for recurrence at the primary site [1-3].

Histopathologic examination of neck dissection specimens, therefore, provides basic information for diagnosis, staging, and prognosis. Clinicians seldom question the reliability of this examination. Although extranodal spread of metastatic carcinoma from cervical nodes is a major prognostic factor [4-6], the clinical implications of micrometastases remain unclear.

The demonstration of micrometastases in a neck dissection specimen deemed to be pathologically negative after routine examination, resulting in upstaging, seems to be more important than the finding of additional micrometastases in a resection specimen with overt nodal disease. We conducted a retrospective study to determine whether serial sectioning and immunohistochemistry using an antibody against cytokeratin, a marker of epithelial cells, could detect occult micrometastases in initially pN0 neck dissection specimens [7].

Patients and Methods

Tissue Selection

Selected for reassessment of neck dissection specimens were the paraffin(Drug information on paraffin)-embedded lymph nodes of 60 previously untreated patients who presented from June 1986 to December 1990. These patients had primary squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx; underwent laser microsurgery on the primary tumor and a unilateral or bilateral neck dissection; and were classified as pN0 after routine histopathologic examination. Ipsilateral neck dissection was carried out in 44 patients and bilateral dissection in 16 patients, so that a total of 76 neck dissection specimens were evaluated. The primary sites were as follows: oral cavity (19 patients), oropharynx (6), hypopharynx (9), glottis (13), and supraglottis (17).

Clinical Staging and Neck Dissection

Preoperative staging of the neck nodes was done by palpation and ultrasonography. Computed tomography (CT), magnetic resonance imaging (MRI), and aspiration cytology were not employed routinely. The neck dissections, either elective (prophylactic) or therapeutic (when positive nodes were clinically suspected), were selective [8]; ie, they were confined to the lymph node groups in which metastases from the specific primary tumor are most likely to occur [9,10]. In patients with laryngeal and oropharyngeal primaries, levels II and III were removed, whereas in those with oral carcinoma, levels I, II, and III were dissected (supraomohyoid neck dissection), and in those with hypopharyngeal primaries, levels II, III, and IV were removed (lateral neck dissection) (Figure 1). The nonlymphatic structures (sternocleidomastoid muscle, internal jugular vein, and spinal accessory nerve) were preserved.

Histopathologic Techniques

For routine examination, the neck dissections specimens were fixed in formalin. All visible or palpable lymph nodes were dissected free of surrounding fat. All nodes ³ 5 mm were cut in half and were then embedded in toto for histologic examination. The "original" surgical pathologic diagnosis was based on microscopic examination of two to three 1-mm sections from each node stained with hematoxylin and eosin (H & E).

Subsequent to this "original" examination, the paraffin-embedded lymph nodes were totally sectioned into 1-mm sections. Every 10th section was stained with H & E, and every 50th section was obtained for immunostaining. A mouse monoclonal antibody to pan-cytokeratin was used for immunostaining. This antibody reacts with human cyto-keratin of 40, 46, 52, 56, 58, and 65 to 67 kD. To make the antigen (cytokeratin)/antibody reaction visible, the classic alkaline phosphatase antialkaline phosphatase (APAAP) technique was used [11]. In this technique, the APAAP complex is stained with neufuchsin, which causes the keratin-positive cells to turn red. The remaining tissue is made visible by counterstaining with hematoxylin.

Since there is no agreed upon definition of micrometastases, the International Union Against Cancer (UICC) definition for axillary lymph node micrometastases from breast carcinoma was used. According to this definition, micrometastases include metastatic deposits of up to 2 mm in diameter.

Results

Overall, 1,020 lymph nodes from 76 initially pN0 neck dissection specimens were examined. On average, 13.5 lymph nodes were found in each of the specimens. The largest axial diameter of each node was recorded. The nodes were 1 to 22 mm in diameter. A total of 5,999 sections were stained with H & E, and 1,261 sections were immunostained.

Eight lymph nodes (.8%) harbored metastases of a squamous cell carcinoma, shown in the H & E-stained sections. All metastases were micrometastases, located in the subcapsular sinus of the lymph node, and all were found in nodes from level II (upper jugular group). Six micrometastases were found in lymph nodes < 10 mm in diameter. Two metastases were detected in nodes 20 mm in diameter. The examination revealed no larger metastases and no extranodal spread. Im-munostaining found the same eight metastases but no additional metastases.

Reevaluation of the original slides revealed that three of these eight metastases had been present but were overlooked. The overlooked metastases were composed of 200 to 500 tumor cells each; the original microscopic slides had shown 4 to 6 tumor cells (Figures 2 and 3).

The eight micrometastases were found in six patients (Table 1), two of whom had two metastases. The primary tumor was located in the oral cavity in three patients, the oropharynx in two patients, and the piriform sinus in one patient. Neither serial sectioning nor immunostaining revealed micrometastases in patients with glottic or supraglottic primaries.

Two of the six patients with micrometastases had been subjected to postoperative adjuvant radiotherapy because of positive microscopic resection margins, despite re-resection of the primary. Another 4 of the total 60 patients had been irradiated for the same reason. With a median follow-up period of 37 months, none of the 60 patients developed recurrent metastasis in the neck. Local recurrences developed in seven patients, and a second primary tumor occurred in five patients. No distant metastases were observed.

Pages: 1  2  
Next
 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 52-Year-Old Man Presents With an Erythematous Lesion
Cesar Moran, MD , May 22, 2013

A 52-year-old man presented with an erythematous lesion in the axilla of unknown duration. Surgical excision was performed. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Colorectal Cancer Treatments and Therapy Innovations
  • A 52-Year-Old Man Presents With an Erythematous Lesion
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy